|
Variables
|
n (%)
|
|---|
|
Sex
|
|
Male
|
21 (75.0)
|
|
Female
|
7 (25.0)
|
|
Age (years)
|
|
<60
|
20 (71.4)
|
|
≥60
|
8 (28.6)
|
|
Type of chronic hepatitis
|
|
Hepatitis B
|
24 (85.7)
|
|
Hepatitis C
|
4 (14.3)
|
|
Cirrhosis
|
|
Yes
|
26 (92.9)
|
|
No
|
2 (7.1)
|
|
AFP(ng/ml)
|
|
<200
|
22 (78.6)
|
|
≥200
|
6 (21.4)
|
|
Child-Pugh classification
|
|
A
|
24 (85.7)
|
|
B
|
4 (14.3)
|
|
ECOG Score
|
|
0
|
25 (89.3)
|
|
1
|
3 (10.7)
|
|
Tumor diameter (cm)
|
|
≤2 cm
|
14 (50.0)
|
|
>2 cm,≤3 cm
|
14 (50.0)
|
|
Use of fiducials in SBRT
|
|
Yes
|
27 (96.4)
|
|
No
|
1 (3.6)
|
|
Previous treatments
|
|
No
|
10 (35.7)
|
|
Resection
|
2 (7.1)
|
|
TACE
|
13 (46.4)
|
|
Resection+TACE
|
1 (3.6)
|
|
TACE+RFA
|
1 (3.6)
|
|
TACE+PCA
|
1 (3.6)
|
- NOTE. Data presented as No (%)
- Abbreviations: AFP alpha-fetoprotein, SBRT stereotactic body radiation therapy, TACE transarterial chemoembolization, RFA radiofrequency ablation, PCA percutaneous cryoablation
